This photo provided by Eli Lilly shows the drug bamlanivimab. On Monday, Nov. 9, 2020, the Food and Drug Administration cleared emergency use of bamlanivimab, the first antibody drug to help the immune system fight COVID-19. The drug is for people 12 and older with mild or moderate COVID-19 not requiring hospitalization. (Courtesy of Eli Lilly via AP)
Southern California wildfire destroys 132 structures as officials look for fierce winds to subside Shares
Ovechkin scoring another game-winning goal for the Capitals comes as no surprise to the Predators Shares
4 astronauts return to Earth after being delayed by Boeing's capsule trouble and Hurricane Milton Shares